Unlike standard GLP-1s, Mounjaro targets both GLP-1 and GIP receptors to optimize how your body breaks down sugar and fat
I am excited to see where month six takes me
Kuckelman, Novos senior vice president and general counsel, said Novo welcomes competition grounded in science, but it cannot stand by as advertising continues to withhold the information patients need, saying Lillys misleading ads leave patients with the mistaken impression that Lilly's drugs are vastly superior, and that is simply not true. In a statement earlier this week, Lilly said it stood by its ads, calling them "truthful," "transparent" and grounded in the most direct scientific evidence available - exactly what patients deserve. What Did Novo Nordisk Allege In Its Lawsuit
.... Verified Client Neo Mooki - GB May 19, 2020
Thank you for believing in me
This is a premium protocol in both cost and complexity